Inspire Medical Systems (INSP) Capital Expenditures Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn | 37.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.36% |
| Dec 31, 2025 | 51.13% |
| Sep 30, 2025 | -28.25% |
| Jun 30, 2025 | 843.91% |
| Mar 31, 2025 | 39.13% |
| Dec 31, 2024 | 73.73% |
| Sep 30, 2024 | -33.10% |
| Jun 30, 2024 | -43.52% |
| Mar 31, 2024 | 60.46% |
| Dec 31, 2023 | 136.93% |
| Sep 30, 2023 | 79.17% |
| Jun 30, 2023 | 133.57% |
| Mar 31, 2023 | 145.06% |
| Dec 31, 2022 | -21.10% |
| Sep 30, 2022 | 66.76% |
| Jun 30, 2022 | -26.06% |
| Mar 31, 2022 | 64.09% |
| Dec 31, 2021 | -181.11% |
| Jun 30, 2021 | 217.42% |
| Mar 31, 2021 | 473.59% |
| Dec 31, 2020 | 113.57% |
| Sep 30, 2020 | 113.99% |
| Jun 30, 2020 | 167.07% |
| Mar 31, 2020 | 7.37% |